Drug Discovery Targeting Metalloenzymes

Comprehensively reviews database establishment, computational tools, experimental strategies, and biochemistry/crystallographic studies of metalloenzymes and their drug discovery applications. 1. Advances in Database and Computational Tools for Drug Discovery Targeting Metalloenzymes
2. Metal-Binding Pharmacophores for Metalloenzyme Drug Discovery
3. Multiscale Computational Approaches in Metal?Ligand Interactions in Drug Design
4. Modelling Metalloenzyme Catalytic Mechanisms by QM/MM Calculations
5. Metalloenzyme-specific Scoring Function
6. Experimental Strategies in Metalloenzyme Mechanism Study and Drug Discovery
7. Structural and Chemical Biology of 2-Oxoglutarate-dependent Oxygenases
8. MBL-fold Nucleases in DNA Repair and Drug Discovery
9. Regulatory, Inhibitory Mechanisms and Drug Discovery of Tryptophan/
Indoleamine 2,3-Dioxygenase (TDO/IDO)
10. Histone Deacetylase Inhibitor Discovery
11. Drug Discovery Targeting Phosphodiesterases
12. Metalloenzymes in RNA metabolism
13. Targeting Metallo-¿-lactamases to Combine Antibiotic Resistance
14. Structural Insights and Drug Discovery into Cytochrome P450 Enzymes
15. Drug Discovery Targeting Viral Metalloenzymes
16. Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitors
17. Drug Discovery Targeting Membrane Metalloenzyme CD73
18. Targeting Carbonic Anhydrases for Disease Treatment
19. Bacterial LpxC Inhibitor Discovery
20. Drug Discovery Targeting Human and Fungal CYP51
21. Targeting Autotaxin (ATX) for Therapeutic Intervention
Guo-Bo Li is Professor in the Department of Medicinal Chemistry at Sichuan University, China. His research group now focuses on development of new computational tools, new data resources and new web servers to assist basic science and drug discovery research particularly targeting metalloenzymes, and development of new chemical probes, new hits/leads or drug candidates to exploit metalloenzyme biological/pathological roles and therapeutical potentials.